COVID-19 vaccine, viral vector-AstraZeneca (Investigational)

Brand and Other Names:AZD-1222 (AstraZeneca)
  • Print
Sections

Dosing & Uses

COVID-19 Disease Prevention

Investigational vaccine for active immunization to prevent coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)

Next:

Pharmacology

Mechanism of Action

Vaccine is composed of a recombinant, replication-incompetent human adenovirus type 26 vector that after entering human cells, expresses the SARS-CoV-2 spike (S) antigen without virus propagation

An immune response elicited to the S antigen protects against COVID-19

Previous
Next:

Images

Previous
Next:
Medscape prescription drug monographs are based on FDA-approved labeling information, unless otherwise noted, combined with additional data derived from primary medical literature.